Al-Omari, Y.W. et al. 2026. Bleeding disorder, a newly recognized adverse event following sacubitril/valsartan therapy. European Journal of Case Reports in Internal Medicine. 13, 4 (Mar. 2026). DOI:https://doi.org/10.12890/2026_006178.